In some cases, we couldn't identify a single executive or clinician publicly associated with the platform
Resource in my B
In a recent study published by Nauck et al., all GLP-1 RAs have a common mechanism of action in terms of controlling blood glucose levels, i.e., increased production of insulin during hyperglycemic states, suppressing glucagon secretion, delayed gastric emptying, preventing postprandial glucose spikes, and lowering caloric intake and BMI [3]
Heres what a typical week of eating looks like for me
GLP-1 receptor agonists mimic the GLP-1 hormone that is naturally released in the gastrointestinal tract in response to eating
Butsch also points out that there arent any official or standard guidelines for microdosing semaglutide or tirzepatide, and microdosing isnt endorsed by the American Diabetes Association